Autres langues Bionime Corporation

Actions

4737

TW0004737002

Equipement, fournitures et distribution médicale

Cours en clôture Taiwan S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
55,40 ^TWD	-0,36%		-4,32%	-6,89%

12/08	Bionime Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
13/07	Bionime obtient la certification européenne pour son système de surveillance du glucose ; l'action bondit de 10 %	MT

Autres langues

12/08	Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/07	Bionime Gets European Regulator's Certification for Glucose Monitoring System; Shares Jump 10%
14/05	Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
16/03	Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
13/11	Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
12/08/25	Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
17/06/25	Bionime Corporation Approves Amendment to the Article of Incorporation
12/05/25	Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
10/04/25	Bionime Sees No Impact from US Reciprocal Tariffs
12/11/24	Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
14/08/24	Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
08/08/24	Bionime Corporation Announces Financial Officer Changes
28/06/24	Bionime Corporation Approves Cash Dividends, Payable on August 23, 2024
10/05/24	Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
15/03/24	Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
14/03/24	Bionime Corporation Announces Dividend for the Year Ended December 31, 2023
10/11/23	Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
13/10/23	Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License
18/08/23	Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer
10/08/23	Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
09/08/23	Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee
30/06/23	Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee
30/06/23	Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023
30/06/23	Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director
11/05/23	Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023